Cargando…

Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation

SIMPLE SUMMARY: Liver transplantation is considered the first-choice curative therapy for hepatocellular carcinoma in the early phase of the disease, when surgical resection is not possible. Even when implementing restrictive criteria to select patients for liver transplantation, there is a risk of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Degroote, Helena, Geerts, Anja, Verhelst, Xavier, Van Vlierberghe, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221160/ https://www.ncbi.nlm.nih.gov/pubmed/35740638 http://dx.doi.org/10.3390/cancers14122973

Ejemplares similares

Rare case of ascites several years after liver transplantation
por: Deroo, Liesbeth, et al.
Publicado: (2022)

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
por: Vandierendonck, Astrid, et al.
Publicado: (2021)

Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium
por: Verhelst, Xavier, et al.
Publicado: (2021)

Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model
por: Vanderborght, Bart, et al.
Publicado: (2020)

Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models
por: Degroote, Helena, et al.
Publicado: (2021)

Cerebellar stroke in a low cardiovascular risk patient associated with sorafenib treatment for fibrolamellar hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2014)

Focal eosinophilic infiltration of the liver, benign or malignant?
por: Claeys, Wouter, et al.
Publicado: (2021)

Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
por: Bogaerts, Eliene, et al.
Publicado: (2016)

The neurogliovascular unit in hepatic encephalopathy
por: Claeys, Wouter, et al.
Publicado: (2021)

Severe Hepatic and Pulmonary Involvement in Rendu-Osler-Weber Syndrome
por: Verhelst, Xavier, et al.
Publicado: (2018)

Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma
por: Degroote, H., et al.
Publicado: (2018)

R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
por: Costentin, Charlotte, et al.
Publicado: (2022)

Secondary Adrenal Insufficiency after Treatment with Budesonide for Autoimmune Hepatitis
por: De Maeyer, Filip, et al.
Publicado: (2018)

Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2016)

Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2016)

Time-Dependent Effect of Hypoxia on Tumor Progression and Liver Progenitor Cell Markers in Primary Liver Tumors
por: Bogaerts, Eliene, et al.
Publicado: (2015)

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
por: Straś, Wojciech Andrzej, et al.
Publicado: (2022)

Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis
por: Paridaens, Annelies, et al.
Publicado: (2017)

Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2014)

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form
por: Schuermans, Wim, et al.
Publicado: (2016)

Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma
por: Heits, Nils, et al.
Publicado: (2018)

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
por: Degroote, Helena, et al.
Publicado: (2021)

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)

Prediction of Early Recurrence of Solitary Hepatocellular Carcinoma after Orthotopic Liver Transplantation
por: Feng, Jiliang, et al.
Publicado: (2019)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)

Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant
por: Pagano, Duilio, et al.
Publicado: (2019)

Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
por: Citores, Maria J, et al.
Publicado: (2019)

Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Tang, Yunhua, et al.
Publicado: (2021)

Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation
por: Xia, Weiliang, et al.
Publicado: (2015)

Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
por: Ma, Ka Wing, et al.
Publicado: (2019)

External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: van Hooff, Maria C., et al.
Publicado: (2022)

Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
por: Kim, Sang Jin, et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence
por: Rahimi, Robert S., et al.
Publicado: (2015)

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
por: Kim, Jong Man
Publicado: (2021)

Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022)

Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
por: Lominadze, Zurabi, et al.
Publicado: (2023)

Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant
por: Guo, Yuxin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jm3rkdh4djcpf0nacjiue1qtha